Home › NDC Lookup › Drug shortages › Sodium Oxybate Solution

Sodium Oxybate Solution shortage

Sodium Oxybate Solution is currently listed in shortage by the FDA. The FDA lists 1 affected product. This page was last refreshed from FDA data on Oct 2, 2026.

To Be Discontinued ⚠ Supply risk: High Controlled substance Psychiatry 1 product 277 days First posted Dec 29, 2025 Updated Dec 29, 2025
Here’s the bottom line

Amneal Pharmaceuticals is stopping its sodium oxybate solution, and the change may be permanent. The same medicine is still listed by other makers, including Xyrem (sodium oxybate) solution from Jazz Pharmaceuticals.

Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).

Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →
1
Affected NDCs
1
Reporting manufacturers
0/1
Reporting mfrs supplying
0/1
Affected strengths supplied
277
Days in shortage
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Oct 2, 2026 · today

What’s in shortage — at a glance

These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Sodium Oxybate Solution. Other makers that haven’t reported a problem are shown in the green card below.

Availability of affected NDCs
From the FDA shortage report
1 NDCs
To be discontinued 1
Affected strengths still supplied
Among manufacturers reporting this shortage
0/1 strengths
No supply 1
FDA-reporting manufacturers with supply
Among manufacturers reporting this shortage
0/1 makers
No supply 1
✓ Other manufacturers not reporting a shortage
Still-marketed Sodium Oxybate Solution from companies that have not filed an FDA shortage — these are not counted in the figures above. Stock can still vary by pharmacy.
Hikma Pharmaceuticals USA Inc. Camber Pharmaceuticals, Inc. Amneal Pharmaceuticals LLC Jazz Pharmaceuticals, Inc.
Plus 5 alternative dosage forms of Sodium Oxybate.
See all other options & details →
Shortage timeline
  1. Dec 29, 2025
    Currently in shortage
    1 of 1 product affected.
  2. Dec 29, 2025
    First reported to the FDA
    1 product first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

What exactly is on backorder — by manufacturer

Manufacturer: Amneal Pharmaceuticals 📞 800-525-7270 1 NDC click to expand
Status NDC / product Strength Availability Related information Reason
To Be Discontinued Sodium Oxybate, Solution, .5 g/1 mL (NDC 69238-2391-1) NDC 69238-2391-01 — — Discontinuation of the manufacture of the drug —

These rows are manufacturer reports to the FDA for Sodium Oxybate Solution — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Sodium Oxybate Solution? options further down this page.

Why is Sodium Oxybate Solution in shortage?

Amneal Pharmaceuticals has reported to the FDA that they are permanently stopping the manufacture of their sodium oxybate oral solution, 0.5 g/1 mL (the liquid concentration). No specific reason for this decision was shared publicly — the FDA report simply notes it as a discontinuation of manufacturing.

It's worth knowing that this report only covers Amneal's specific product. It does not mean sodium oxybate solution is going away from every manufacturer — other companies that make this medication are listed separately and are not part of this particular report.

Based on the manufacturer-reported reason(s) and notes on file with the FDA for Sodium Oxybate Solution, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.

What should I do if I take Sodium Oxybate Solution?

Sodium oxybate oral solution is currently on the FDA shortage list, and I want to walk you through what that means for you.

The strength involved is the 0.5 g/mL solution. Right now, this strength has no available source from the manufacturer that filed this report (Amneal Pharmaceuticals). Because no other strength of this product is on the record, there isn't a separate strength still in supply to point you toward here.

The reason listed is that the maker is discontinuing manufacture of this product. That means this particular supply problem may be permanent rather than temporary. Importantly, this report reflects only one manufacturer — other companies may still make the same medicine, so this does not mean sodium oxybate is gone everywhere.

Here is what I suggest, in order:

  1. Do not stop, skip, or change your dose on your own.
  2. Because Amneal's product is being discontinued, ask your prescriber or pharmacist about next steps soon, rather than waiting.
  3. The same medicine (sodium oxybate solution, 0.5 g/mL) may be available from other makers — Hikma, Camber, or as Xyrem from Jazz. Your pharmacy can try to source one, though it may not be on the local shelf.
  4. Manufacturer contact numbers are listed on this page for reference; pharmacies usually make these calls.

This is general, national information and may not match your pharmacy's actual stock.

See “Where else can I get Sodium Oxybate Solution?” below ↓ The same medicine from manufacturers not reporting a shortage, alternative dosage forms, and therapeutic equivalents with pricing.
If you are a patient:
  • Don’t stop or change the medication on your own — talk to your prescriber first.
  • If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
  • Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
  • Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
  • This is a controlled substance. Transfers between pharmacies and switching strengths have extra federal/state rules — ask the pharmacy before you assume a transfer is possible.
Keep reading
Our full Sodium Oxybate guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Sodium Oxybate guide →

Where else can I get Sodium Oxybate Solution?

FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Sodium Oxybate Solution is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same medicine, other manufacturers (not reported short)

Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:

ProductStrengthForm / routeManufacturerNDC
Sodium Oxybate SODIUM OXYBATE .5 g/mL Solution · Oral Hikma Pharmaceuticals USA Inc. 00054-9628-57
Sodium Oxybate SODIUM OXYBATE .5 g/mL Solution · Oral Camber Pharmaceuticals, Inc. 31722-0891-18
Sodium Oxybate SODIUM OXYBATE 500 mg/mL Solution · Oral Amneal Pharmaceuticals LLC 65162-0065-87
Xyrem SODIUM OXYBATE .5 g/mL Solution · Oral Jazz Pharmaceuticals, Inc. 68727-0100-01

Alternative dosage forms of Sodium Oxybate

A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:

Therapeutic equivalents & pricing 6 productsclick to expand

Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
sodium oxybate .5 g/mLNDC 00054-9628-57 Hikma 180 ml — AA FDA listed
sodium oxybate .5 g/mLNDC 31722-0891-18 Camber 1 bottle — AA FDA listed
Sodium Oxybate 500 mg/mLNDC 65162-0065-87 Amneal 1 bottle — AA FDA listed
Xyrem .5 g/mLNDC 68727-0100-01 Jazz 180 ml — AA FDA listed
sodium oxybate .5 g/mLNDC 72865-0349-18 XLCare 1 bottle — AA FDA listed
sodium oxybate 0.5 g/mLNDC 69238-2391-01 Amneal 180 ml — AA Discontinued

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Other drugs in the same treatment class

These are different medicines — not other versions of Sodium Oxybate Solution — that fall in the same broad treatment class (anti-narcolepsy,anti-cataplexy,sedative-type agent) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Identity & classification

GCN Seq No 050813
GCN 18104
HICL code 012346
Ingredient (HICL) Sodium Oxybate
HIC1 code H
Therapeutic class — broad (HIC1) Nervous System (Except Autonomic)
HIC2 code H7
Therapeutic class — intermediate (HIC2) Psychoactive Drugs (Continued 1)
HIC3 code H7W
Therapeutic class — specific (HIC3) Anti-Narcolepsy,Anti-Cataplexy,Sedative-Type Agent
AHFS code 28:20.80.00
AHFS class Wakefulness-Promoting Agents
FDB label name SODIUM OXYBATE 0.5 G/ML SOLN
FDB brand name Sodium Oxybate
Legend status F — Federal legend — prescription drug or device
DEA scheduleCIII
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Other psychiatry shortages

Sodium Oxybate Solution shortage FAQs

Is Sodium Oxybate Solution in shortage?
Yes — the FDA currently lists Sodium Oxybate Solution in shortage (status: “To Be Discontinued”, first reported Dec 29, 2025). 1 of 1 product is affected. This is national, manufacturer-reported data, so your pharmacy may still have stock.
Which products are affected?
Sodium Oxybate, Solution, .5 g/1 mL (NDC 69238-2391-1) (NDC 69238-2391-01). The full per-NDC list (availability, manufacturer and status) is in the table above — each NDC links to its own page.
When will Sodium Oxybate Solution be available again?
The FDA does not publish a guaranteed restock date, and no estimated-recovery note is on file. Availability can change daily — confirm with your pharmacy.
Can I still get Sodium Oxybate somewhere?
Other manufacturers (Hikma Pharmaceuticals USA Inc., Camber Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC and others) still market it and have not reported a shortage. 5 alternative dosage forms of Sodium Oxybate are also listed. See “Where else can I get Sodium Oxybate Solution?” above — stock still varies by pharmacy.
What should I do if I take Sodium Oxybate Solution?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another manufacturer or a different strength/package size, and ask your prescriber about a long-term plan before your supply runs out. Because this is a controlled substance, transfers and substitutions have extra federal/state rules — ask the pharmacy first.

Still have a question about the Sodium Oxybate Solution shortage?

Ask a pharmacist about this shortage →
How to read the Supply-Risk rating
Low (1–2)Multiple manufacturers still supplying and most strengths or pack sizes sourceable.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes unsourceable, or a long-running outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages